325
Views
2
CrossRef citations to date
0
Altmetric
Articles

Systematic review of economic evaluation studies on preconception care interventions

ORCID Icon, &
Pages 503-517 | Received 30 Jan 2020, Accepted 25 Aug 2020, Published online: 17 Sep 2020

References

  • Bertram, M. Y., Lauer, J. A., De Joncheere, K., Edejer, T., Hutubessy, R., Kieny, M.-P., & Hill, S. R. (2016). Cost-effectiveness thresholds: Pros and cons. Bulletin of the World Health Organization, 94(12), 925–930. https://doi.org/10.2471/BLT.15.164418
  • Bhutta, Z. A., Das, J. K., Bahl, R., Lawn, J. E., Salam, R. A., Paul, V. K., Sankar, M. J., Blencowe, H., Rizvi, A., Chou, V. B., & Walker, N. (2014). Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?. The Lancet, 384(9940), 347–370. https://doi.org/10.1016/S0140-6736(14)60792-3
  • Boulet, S. L., Parker, C., & Atrash, H. (2006). Preconception care in international settings. Maternal and Child Health Journal, 10(5 Suppl), S29–S35. https://doi.org/10.1007/s10995-006-0091-1
  • de Weerd, S., Polder, J. J., Cohen-Overbeek, T. E., Zimmermann, L. J. I., & Steegers, E. A. P. (2004). Preconception care: Preliminary estimates of costs and effects of smoking cessation and folic acid supplementation. The Journal of Reproductive Medicine, 49(5), 338–344.
  • Dean, S., Rudan, I., Althabe, F., Webb Girard, A., Howson, C., Langer, A., Lawn, J., Reeve, M.-E., Teela, K. C., Toledano, M., Venkatraman, C.-M., Belizan, J. M., Car, J., Chan, K. Y., Chatterjee, S., Chitekwe, S., Doherty, T., Donnay, F., Ezzati, M., … Bhutta, Z. A. (2013a). Setting research priorities for preconception care in low- and middle-income countries: Aiming to reduce maternal and child mortality and morbidity. PLoS Medicine, 10(9), e1001508. https://doi.org/10.1371/journal.pmed.1001508
  • Dean, S. V., Imam, A. M., Lassi, Z. S., & Bhutta, Z. A. (2013b). Importance of intervening in the preconception period to impact pregnancy outcomes. Nestle Nutrition Institute Workshop Series, 74, 63–73. https://doi.org/10.1159/000348402
  • Dean, S. V., Lassi, Z. S., Imam, A. M., & Bhutta, Z. A. (2014). Preconception care: Closing the gap in the continuum of care to accelerate improvements in maternal, newborn and child health. Reproductive Health, 11 (Suppl 3), S1. https://doi.org/10.1186/1742-4755-11-S3-S1
  • Donaldson, C., Currie, G., & Mitton, C. (2002). Cost effectiveness analysis in health care: Contraindications. BMJ (Clinical Research ed.), 325(7369), 891–894. https://doi.org/10.1136/bmj.325.7369.891
  • Drummond, M. F., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & S, G. (2005). Methods for the economic evaluation of health care programmes (3rd ed.). Oxford University Press.
  • Egan, A. M., Danyliv, A., Carmody, L., Kirwan, B., & Dunne, F. P. (2016). A prepregnancy care program for women with diabetes: Effective and cost saving. The Journal of Clinical Endocrinology & Metabolism, 101(4), 1807–1815. https://doi.org/10.1210/jc.2015-4046
  • Elixhauser, A., Weschler, J. M., Kitzmiller, J. L., Marks, J. S., Bennert, H. W., Coustan, D. R., Gabbe, S. G., Herman, W. H., Kaufmann, R. C., & Ogata, E. S. (1993). Cost-benefit analysis of preconception care for women with established diabetes mellitus. Diabetes Care, 16(8), 1146–1157. https://doi.org/10.2337/diacare.16.8.1146
  • ESHRE Capri Workshop Group. (2015). Economic aspects of infertility care: A challenge for researchers and clinicians. Human Reproduction (Oxford, England), 30(10), 2243–2248. https://doi.org/10.1093/humrep/dev163
  • Fischl, A. F. R., Herman, W. H., Sereika, S. M., Hannan, M., Becker, D., Mansfield, M. J., Freytag, L. L., Milaszewski, K., Botscheller, A. N., & Charron-Prochownik, D. (2010). Impact of a preconception counseling program for teens with type 1 diabetes (READY-Girls) on patient-provider interaction, resource utilization, and cost. Diabetes Care, 33(4), 701–705. https://doi.org/10.2337/dc09-1821
  • Goldhaber-Fiebert, J. D., & Brandeau, M. L. (2015). Evaluating cost-effectiveness of interventions that affect fertility and childbearing: How health effects are measured matters. Medical Decision Making, 35(7), 818–846. https://doi.org/10.1177/0272989X15583845
  • Herman, W. H., Janz, N. K., Becker, M. P., & Charron-Prochownik, D. (1999). Diabetes and pregnancy. Preconception care, pregnancy outcomes, resource utilization and costs. The Journal of Reproductive Medicine, 44(1), 33–38.
  • Korenbrot, C. C., Steinberg, A., Bender, C., & Newberry, S. (2002). Preconception care: A systematic review. Maternal and Child Health Journal, 6(2), 75–88. https://doi.org/10.1023/A:1015460106832
  • Lassi, Z. S., Dean, S. V., Mallick, D., & Bhutta, Z. A. (2014). Preconception care: Delivery strategies and packages for care. Reproductive Health, 11 (Suppl 3), S7. https://doi.org/10.1186/1742-4755-11-S3-S7
  • Mason, E., Chandra-Mouli, V., Baltag, V., Christiansen, C., Lassi, Z. S., & Bhutta, Z. A. (2014). Preconception care: Advancing from “important to do and can be done” to “is being done and is making a difference. Reproductive Health, 11(S3), S8. https://doi.org/10.1186/1742-4755-11-S3-S8
  • Pérez Velasco, R., Praditsitthikorn, N., Wichmann, K., Mohara, A., Kotirum, S., Tantivess, S., Vallenas, C., Harmanci, H., & Teerawattananon, Y. (2012). Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics. PloS One, 7(2), e30333. https://doi.org/10.1371/journal.pone.0030333
  • Peterson, C., Grosse, S. D., Li, R., Sharma, A. J., Razzaghi, H., Herman, W. H., & Gilboa, S. M. (2015). Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States. American Journal of Obstetrics and Gynecology, 212(1), 74.e1. https://doi.org/10.1016/j.ajog.2014.09.009
  • Scheffler, R. M., Feuchtbaum, L. B., & Phibbs, C. S. (1992). Prevention: The cost-effectiveness of the California Diabetes and Pregnancy Program. American Journal of Public Health, 82(2), 168–175. https://doi.org/10.2105/AJPH.82.2.168
  • Shannon, G. D., Alberg, C., Nacul, L., & Pashayan, N. (2013). Preconception health care and congenital disorders: Mathematical modelling of the impact of a preconception care programme on congenital disorders. BJOG: An International Journal of Obstetrics & Gynaecology, 120(5), 555–566. https://doi.org/10.1111/1471-0528.12116
  • Simon, C., & Romero, R. (2019). Preconceptional care, where reproductive medicine meets obstetrics: The origins of lifetime health. Fertility and Sterility, 111(4), 657–658. https://doi.org/10.1016/j.fertnstert.2019.02.006
  • Singh, S., Sedgh, G., & Hussain, R. (2010). Unintended pregnancy: Worldwide levels, trends, and outcomes. Studies in Family Planning, 41(4), 241–250. https://doi.org/10.1111/j.1728-4465.2010.00250.x
  • Thiboonboon, K., Kulpeng, W., & Teerawattananon, Y. (2018). An economic analysis of chromosome testing in couples with children who have structural chromosome abnormalities. PloS One, 13(6), e0199318. https://doi.org/10.1371/journal.pone.0199318
  • Toledano-Alhadef, H., Basel-Vanagaite, L., Magal, N., Davidov, B., Ehrlich, S., Drasinover, V., Taub, E., Halpern, G. J., Ginott, N., & Shohat, M. (2001). Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. American Journal of Human Genetics, 69(2), 351–360. https://doi.org/10.1086/321974
  • Verheij, J. B., Wildhagen, M. F., Hofstra, R. M., Pals, G., Habbema, J. D., & ten Kate, L. P. (1999). Preconceptional screening of couples for carriers of cystic fibrosis: A prospective evaluation of effects, costs and savings for different mutation detection methods. Community Genetics, 2(2-3), 74–81. https://doi.org/10.1159/000016190
  • Walker, D. G., Hutubessy, R., & Beutels, P. (2010). WHO Guide for standardisation of economic evaluations of immunization programmes. Vaccine, 28(11), 2356–2359. https://doi.org/10.1016/j.vaccine.2009.06.035
  • Warren, E., Anderson, R., Proos, A. L., Burnett, L. B., Barlow-Stewart, K., & Hall, J. (2005). Cost-effectiveness of a school-based Tay-Sachs and cystic fibrosis genetic carrier screening program. Genetics in Medicine, 7(7), 484–494. https://doi.org/10.1097/01.gim.0000178496.91670.3b
  • Wildhagen, M. F., Hilderink, H. B., Verzijl, J. G., Verheij, J. B., Kooij, L., Tijmstra, T., ten Kate, L. P., & Habbema, J. D. (1998a). Costs, effects, and savings of screening for cystic fibrosis gene carriers. Journal of Epidemiology and Community Health, 52(7), 459–467. https://doi.org/10.1136/jech.52.7.459
  • Wildhagen, M. F., van Os, T. A., Polder, J. J., ten Kate, L. P., & Habbema, J. D. (1998b). Explorative study of costs, effects and savings of screening for female fragile X premutation and full mutation carriers in the general population. Community Genetics, 1(1), 36–47. https://doi.org/10.1159/000016133
  • World Health Organization [WHO]. (n.d.). Preconception care. Retrieved September 26, 2018, from https://www.who.int/maternal_child_adolescent/documents/preconception_care_policy_brief.pdf
  • Young, C. T., Urquia, M. L., & Ray, J. G. (2013). Preconception care in low- and middle-income countries: New opportunities and a new metric. PLoS Medicine, 10(9), e1001507. https://doi.org/10.1371/journal.pmed.1001507

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.